Potentiation of Anticancer Activity of G


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 16 05 2023
revised: 13 06 2023
accepted: 14 06 2023
medline: 31 7 2023
pubmed: 28 7 2023
entrez: 27 7 2023
Statut: ppublish

Résumé

Hyperthermia (HT), combined with chemotherapy, has been used to treat various types of cancer. This study aimed to investigate the HT-sensitivity of malignant and non-malignant cells, and then evaluate the combination effect of docetaxel (DTX) and a newly synthesized chromone derivative (compound A) with HT. The number of viable cells was determined using the MTT method. Cell cycle distribution was analyzed using a cell sorter, and DNA fragmentation pattern was detected using agarose gel electrophoresis. Among 12 cultured cells, oral squamous cell carcinoma (OSCC), especially Ca9-22 cells, and myelogenous leukemia cells showed higher sensitivity to HT than lung carcinoma and glioblastoma cell lines, while normal oral cells were the most resistant. Cytotoxicity of DTX on Ca9-22 cells was maximum at 41-42°C and 45~60 min exposure to HT. DXT, compound A, and HT induced G The combination G

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Hyperthermia (HT), combined with chemotherapy, has been used to treat various types of cancer. This study aimed to investigate the HT-sensitivity of malignant and non-malignant cells, and then evaluate the combination effect of docetaxel (DTX) and a newly synthesized chromone derivative (compound A) with HT.
MATERIALS AND METHODS METHODS
The number of viable cells was determined using the MTT method. Cell cycle distribution was analyzed using a cell sorter, and DNA fragmentation pattern was detected using agarose gel electrophoresis.
RESULTS RESULTS
Among 12 cultured cells, oral squamous cell carcinoma (OSCC), especially Ca9-22 cells, and myelogenous leukemia cells showed higher sensitivity to HT than lung carcinoma and glioblastoma cell lines, while normal oral cells were the most resistant. Cytotoxicity of DTX on Ca9-22 cells was maximum at 41-42°C and 45~60 min exposure to HT. DXT, compound A, and HT induced G
CONCLUSION CONCLUSIONS
The combination G

Identifiants

pubmed: 37500171
pii: 43/8/3429
doi: 10.21873/anticanres.16518
doi:

Substances chimiques

Docetaxel 15H5577CQD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3429-3439

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Yuya Tagawa (Y)

Division of Oral and Maxillofacial Surgery, Meikai University School of Dentistry, Saitama, Japan.

Hiroshi Sakagami (H)

Meikai University Research Institute of Odontology (M-RIO), Saitama, Japan; sakagami@dent.meikai.ac.jp.

Sei-Ichi Tanuma (SI)

Meikai University Research Institute of Odontology (M-RIO), Saitama, Japan.

Shigeru Amano (S)

Meikai University Research Institute of Odontology (M-RIO), Saitama, Japan.

Shin Uota (S)

Meikai University Research Institute of Odontology (M-RIO), Saitama, Japan.

Kenjiro Bandow (K)

Division of Biochemistry, Meikai University School of Dentistry, Saitama, Japan.

Mineko Tomomura (M)

Division of Biochemistry, Meikai University School of Dentistry, Saitama, Japan.
Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Yoshihiro Uesawa (Y)

Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo, Japan.

Koichi Takao (K)

Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama, Japan.

Yoshiaki Sugita (Y)

Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama, Japan.

Nobuharu Yamamoto (N)

Division of Oral and Maxillofacial Surgery, Meikai University School of Dentistry, Saitama, Japan.

Hideaki Sakashita (H)

Division of Oral and Maxillofacial Surgery, Meikai University School of Dentistry, Saitama, Japan.

Rina Nakakaji (R)

Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Toshiyuki Koizumi (T)

Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Kenji Mitsudo (K)

Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Iwai Tohnai (I)

Meikai University School of Health Sciences, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH